The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(7-(benzyloxy)-1H-indazol-3-yl)-5-(4-(piperidin-1-yl)piperidin-1-yl)-1H-benzo[d]imidazole ID: ALA379995
PubChem CID: 136038570
Max Phase: Preclinical
Molecular Formula: C31H34N6O
Molecular Weight: 506.65
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc(COc2cccc3c(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)[nH]nc23)cc1
Standard InChI: InChI=1S/C31H34N6O/c1-3-8-22(9-4-1)21-38-28-11-7-10-25-29(28)34-35-30(25)31-32-26-13-12-24(20-27(26)33-31)37-18-14-23(15-19-37)36-16-5-2-6-17-36/h1,3-4,7-13,20,23H,2,5-6,14-19,21H2,(H,32,33)(H,34,35)
Standard InChI Key: UIKVMQIVWDEOSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 44 0 0 0 0 0 0 0 0999 V2000
2.9372 -15.2477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9302 -16.0749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6400 -16.4926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6494 -14.8400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3644 -15.2535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3593 -16.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1438 -16.3405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6340 -15.6747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1522 -15.0031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4119 -14.2204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1978 -13.9751 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9315 -13.5549 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4203 -12.8908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2028 -13.1546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8204 -12.6093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6568 -11.8002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8701 -11.5392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2558 -12.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7033 -10.7316 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3265 -10.1835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1624 -9.3789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3807 -9.1154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7626 -9.6627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9263 -10.4736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2170 -8.3071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8374 -7.7668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6764 -6.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8957 -6.6953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2756 -7.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4362 -8.0517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6353 -17.3172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9189 -17.7254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9143 -18.5501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1955 -18.9559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1904 -19.7798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9028 -20.1969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6217 -19.7842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6232 -18.9617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17 18 1 0
18 13 2 0
8 9 1 0
17 19 1 0
19 20 1 0
9 5 2 0
4 1 2 0
9 10 1 0
10 11 1 0
5 6 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
22 25 1 0
25 26 1 0
11 14 1 0
13 12 1 0
12 10 2 0
2 3 2 0
3 6 1 0
25 30 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
13 14 1 0
3 31 1 0
1 2 1 0
31 32 1 0
14 15 2 0
32 33 1 0
5 4 1 0
33 34 2 0
15 16 1 0
34 35 1 0
6 7 2 0
35 36 2 0
16 17 2 0
36 37 1 0
7 8 1 0
37 38 2 0
38 33 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 506.65Molecular Weight (Monoisotopic): 506.2794AlogP: 6.14#Rotatable Bonds: 6Polar Surface Area: 73.07Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.24CX Basic pKa: 9.62CX LogP: 4.95CX LogD: 3.04Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -1.01
References 1. McBride CM, Renhowe PA, Heise C, Jansen JM, Lapointe G, Ma S, Piñeda R, Vora J, Wiesmann M, Shafer CM.. (2006) Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases., 16 (13): [PMID:16603352 ] [10.1016/j.bmcl.2006.03.069 ]